New Drug Formulations: Loop Diuretics Part 2

The new loop diuretic formulations are just so exciting we had to come back for more. (You know we pharmacists love a good study chat!) So this week we’re here to check out a little more of the literature behind the newly approved subcutaneous furosemide formulations so that you are fully armed with the knowledge you need.

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyStephanie KujawskiJune 29, 2026subcutaneous furosemide for heart failure, how to avoid heart failure admissions and readmissions, sc vs iv furosemide, furoscix for heart failure, new drug approvals furoscix

New Drug Approval: Suzetrigine (Journavx)

It’s been a while since we’ve written about a new drug approval, but when there’s a first-in-class, novel agent approved to target the opioid epidemic, that kinda gets a pharmacist’s attention. Wouldn’t you agree? Come learn about suzetrigine so that you can decide whether this analgesic may have a place in your therapy arsenal.

FDA Approval, Clinical, Pharmacy School, Practice, ResidencyStephanie KujawskiFebruary 10, 2025suzetrigine Journavx, non-opioid pain medication analgesia, selective sodium channel blocker for pain, opioid sparing pain medication regimens, how to treat acute pain without an opioid, new drug approval FDA 2025

New FDA Approvals: The Year of NMOSD

Time to dive back into a clinical post! Plus, this one has the added bonus of also being a new drug approval post - times THREE. *mic drop* Come take a look into the world of neuroimmunology, and see what pearls you can take away for your own pharmacy practice.

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyStephanie KujawskiJune 1, 2021new drug approvals by FDA, new drug updates, NMOSD MOG, neuromyelitis optica, immunosuppressants for neurological disorders, NMO versus MS, IVIG uses

New FDA Approval: Fetroja

Because one can never have too many antibiotics at hand when facing armies of wily bacteria, tl;dr is here to give you the low down on the newest sneaky weapon at hand. Even though this latest cephalosporin makes it increasingly difficult to think in terms of the classic generations, come check out cefiderocol and why it’s extra special in the ID world.

Clinical, FDA Approval, Practice, Pharmacy School, ResidencyStephanie KujawskiSeptember 3, 2020cefiderocol, Fetroja, new cephalosporin antibiotic, medications for resistant bacteria, complicated UTI treatment, carbapenemases resistance treatment, siderophore cephalosporin

New FDA Approval: Zemdri

Check it out: a new antibiotic has hit the market! But if and when will you use it?

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyStephanie KujawskiOctober 8, 2018new drug approval, FDA approval, new antibiotics, aminoglycoside, plazomicin, zemdri, ESBL, MDR bacteria, urinary tract infection

New FDA Approval: Epidiolex

Drug

Epidiolex (cannabidiol extract from cannabis)

FDA Approval, Clinical, Pharmacy School, Practice, ProfessionalBrandon DysonAugust 24, 2018fda approval, epidiolex, marijuana legalization, epidiolex cost, epidiolex controlled substance, epidiolex schedule, dravet syndrome treatment, lennox-gastaut treatment, epilepsy treatment

New FDA Approval: Trogarzo

Drug

Ibalizumab-uiyk

Indication

In combination with other antiretrovirals, Trogarzo is indicated for the treatment of HIV-1 in heavily treatment-experienced adults with multi-drug resistant HIV-1 who are failing their current therapy.